---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-032719"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2023-09-21T23:59:59+00:00"
generated_at: "2026-06-10T10:11:23.754627+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Rockwell Medical amends DaVita supply agreement with price increase, one-time payment

## Summary
- DaVita agrees to increased product pricing for dialysis concentrates effective Sept 1, 2023, plus a one-time payment to Rockwell after Dec 1, 2023.
- Amended agreement runs through Dec 31, 2024; DaVita can extend to Dec 31, 2025 with further price increase.
- DaVita must provide 9-month purchase forecasts and commit to buy at least forecasted amounts or pay shortfall.
- Upon termination, Rockwell will provide transition services to DaVita if requested.

## SEC filing metadata
- accession: 0001628280-23-032719
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2023-09-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828023032719/0001628280-23-032719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828023032719/rmti-20230918.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-032719
- JSON: https://secwatch.observer/filing/0001628280-23-032719.json
- Plain text: https://secwatch.observer/filing/0001628280-23-032719.txt

## Key facts
- Material Agreements
  ROCKWELL MEDICAL, INC. amended Amended and Restated Products Purchase Agreement with DaVita Inc. (effective 2023-09-18).
  - Action: amendment
  - Agreement: supply
  - Counterparty: DaVita Inc.
  - Effective: 2023-09-18
  source text: On September 18, 2023, Rockwell Medical, Inc. (the “Company”) and DaVita Inc. (“DaVita”) entered into an Amended and Restated Products Purchase Agreement (the “Amended Agreement”), which amends and restates the Products Purchase Agreement, dated July 1, 2019, as amended, under which the Company supplies DaVita with certain dialysis concentrates.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828023032719/0001628280-23-032719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.